Integrated Diagnostics Holdings (LSE:IDHC) Piotroski F-Score: 3 (As of Jun. 26, 2026) — 50% Below Median


LSE:IDHC Integrated Diagnostics Holdings PLC LSE:IDHC
58 GF Score
Price $0.50
GF Value $0.57
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Integrated Diagnostics Holdings Piotroski F-Score?

Integrated Diagnostics Holdings LSE:IDHC +0.40% 58 Piotroski F-Score is 3 as of Jun. 26, 2026, which is 50% below its 10-year median of 6.00. GuruFocus rates LSE:IDHC with a GF Score™ of 58/100 and a GF Value™ of $0.57 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Integrated Diagnostics Holdings ranks worse than 72.99% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Integrated Diagnostics Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Integrated Diagnostics Holdings's Piotroski F-Score or its related term are showing as below:

LSE:IDHC' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 6   Max: 8
Current: 3

During the past 13 years, the highest Piotroski F-Score of Integrated Diagnostics Holdings was 8. The lowest was 1. And the median was 6.

Integrated Diagnostics Holdings  (LSE:IDHC) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Integrated Diagnostics Holdings Piotroski F-Score Related Terms


Integrated Diagnostics Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Integrated Diagnostics Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings Piotroski F-Score Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 4.00 7.00 6.00 4.00

Integrated Diagnostics Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 6.00 6.00 4.00 3.00

LSE:IDHC vs TMO, DHR, IDXX: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Piotroski F-Score falls into.


LSE:IDHC
58GF Score
Integrated Diagnostics Holdings PLC LSE:IDHC
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Jun24) TTM:
Net Income was 0 + 4.843 + 0 + 9.197 = $14.04 Mil.
Cash Flow from Operations was 0 + 0 + 0 + 0 = $0.00 Mil.
Revenue was 0 + 31.292 + 0 + 43.629 = $74.92 Mil.
Gross Profit was 0 + 12.473 + 0 + 16.984 = $29.46 Mil.
Average Total Assets from the begining of this year (Jun24)
to the end of this year (Mar26) was
(143.783 + 141.888 + 140.994 + 0 + 180.898) / 5 = $151.89075 Mil.
Total Assets at the begining of this year (Jun24) was $143.78 Mil.
Long-Term Debt & Capital Lease Obligation was $25.14 Mil.
Total Current Assets was $83.17 Mil.
Total Current Liabilities was $56.77 Mil.
Net Income was 5.754 + 3.524 + 9.254 + 2.368 = $20.90 Mil.

Revenue was 38.247 + 34.577 + 25.942 + 27.823 = $126.59 Mil.
Gross Profit was 15.526 + 12.511 + 9.491 + 10.411 = $47.94 Mil.
Average Total Assets from the begining of last year (Jun23)
to the end of last year (Jun24) was
(180.791 + 177.08 + 185.433 + 186.675 + 143.783) / 5 = $174.7524 Mil.
Total Assets at the begining of last year (Jun23) was $180.79 Mil.
Long-Term Debt & Capital Lease Obligation was $22.61 Mil.
Total Current Assets was $52.54 Mil.
Total Current Liabilities was $34.89 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Integrated Diagnostics Holdings's current Net Income (TTM) was 14.04. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Integrated Diagnostics Holdings's current Cash Flow from Operations (TTM) was 0.00. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun24)
=14.04/143.783
=0.09764715

ROA (Last Year)=Net Income/Total Assets (Jun23)
=20.9/180.791
=0.1156031

Integrated Diagnostics Holdings's return on assets of this year was 0.09764715. Integrated Diagnostics Holdings's return on assets of last year was 0.1156031. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Integrated Diagnostics Holdings's current Net Income (TTM) was 14.04. Integrated Diagnostics Holdings's current Cash Flow from Operations (TTM) was 0.00. ==> 0.00 <= 14.04 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Mar26
=25.141/151.89075
=0.16552028

Gearing (Last Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=22.611/174.7524
=0.12938878

Integrated Diagnostics Holdings's gearing of this year was 0.16552028. Integrated Diagnostics Holdings's gearing of last year was 0.12938878. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=83.171/56.774
=1.46494874

Current Ratio (Last Year: Jun24)=Total Current Assets/Total Current Liabilities
=52.544/34.886
=1.50616293

Integrated Diagnostics Holdings's current ratio of this year was 1.46494874. Integrated Diagnostics Holdings's current ratio of last year was 1.50616293. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Integrated Diagnostics Holdings's number of shares in issue this year was 581.326. Integrated Diagnostics Holdings's number of shares in issue last year was 600. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=29.457/74.921
=0.39317414

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=47.939/126.589
=0.37869799

Integrated Diagnostics Holdings's gross margin of this year was 0.39317414. Integrated Diagnostics Holdings's gross margin of last year was 0.37869799. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun24)
=74.921/143.783
=0.52106995

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun23)
=126.589/180.791
=0.70019525

Integrated Diagnostics Holdings's asset turnover of this year was 0.52106995. Integrated Diagnostics Holdings's asset turnover of last year was 0.70019525. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+0+0+1+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Integrated Diagnostics Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
Integrated Diagnostics Holdings (LSE:IDHC) has a Piotroski F-Score of 3 as of Jun. 26, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Integrated Diagnostics Holdings and its competitors. This is 50% below median its historical median of 6.00. Over the past decade, Integrated Diagnostics Holdings' Piotroski F-Score has ranged from 1.00 to 8.00. According to the industry distribution chart, Integrated Diagnostics Holdings ranks #154 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 73%.
Is Integrated Diagnostics Holdings' Piotroski F-Score too high?
Integrated Diagnostics Holdings' current Piotroski F-Score of 3 is 50% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Integrated Diagnostics Holdings' value of 3 is 40% below this industry median. Based on the distribution chart, Integrated Diagnostics Holdings ranks #154 out of 211 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Integrated Diagnostics Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integrated Diagnostics Holdings' Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integrated Diagnostics Holdings ranks #154 out of 211 companies for Piotroski F-Score. This places Integrated Diagnostics Holdings in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Integrated Diagnostics Holdings' value of 3 is 40% below this benchmark. Historically, Integrated Diagnostics Holdings' own Piotroski F-Score has ranged from 1.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Integrated Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 211 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Diagnostics Holdings's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Integrated Diagnostics Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Diagnostics Holdings's current Piotroski F-Score is 3, which is 50% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integrated Diagnostics Holdings (LSE:IDHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.57, compared to a current price of $0.50 — trading 11.9% below its estimated fair value. The current Piotroski F-Score is 3, which is 50% below median its 10-year median of 6.00 and 40% below the Medical Diagnostics & Research industry median of 5.00. Integrated Diagnostics Holdings' overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Integrated Diagnostics Holdings (LSE:IDHC), the current Piotroski F-Score is 3 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued. The current stock price of $0.50 is trading 11.9% below its estimated GF Value™ of $0.57. GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for LSE:IDHC:

  • Piotroski F-Score: 3 (50% below median its 10-year median of 6.00)
  • GF Value™: $0.57 vs. price of $0.50 (11.9% below fair value)
  • GF Score™: 58/100 with 6 warning signs
  • Industry Position: 40% below the Medical Diagnostics & Research median (#154 of 211)

No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrated Diagnostics Holdings Business Description

Address 12 Castle Street, St Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
58GF Score

Get the complete analysis for LSE:IDHC

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.50
Price
$0.57
GF Value